Go Pro

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Stock Chart & Stock Price History

GBX 14.63 +0.00 (+0.03%)
As of 03:28 AM Eastern

VanEck Bionic Engineering UCITS ETF A Acc Stock Price Performance

5 Day
Performance
-0.89%
1 Month
Performance
+7.69%
3 Month
Performance
+14.59%
Year-To-Date
Performance
-6.65%
1 Year
Performance
-3.98%
5 Year
Performance
-89.37%

CYBG Stock Chart for Monday, August, 17, 2026

The VanEck Bionic Engineering UCITS ETF A Acc (CYBG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 3.98%, with a year-to-date return of -6.65%. In the past month, the stock has increased 7.69%, reflecting recent market activity.

As of the latest close, VanEck Bionic Engineering UCITS ETF A Acc traded at GBX 14.62 with a market cap of £209.78 million and volume of 363 shares. Five years ago, the stock traded at GBX 137.60, representing a 89.37% decrease over that period. At the time, it had a market cap of £1.97 billion and a volume of 2.42 million shares. View the advanced CYBG chart on TradingView.

Receive CYBG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VanEck Bionic Engineering UCITS ETF A Acc Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/14/2026GBX 14.76GBX 14.62
-0.89%
GBX 14.79GBX 14.62363 shs£209.78 million
08/13/2026GBX 14.76GBX 14.76
-0.03%
GBX 14.81GBX 14.692 shs£211.67 million
08/12/2026GBX 14.59GBX 14.76
+1.15%
GBX 14.78GBX 14.61822 shs£211.73 million
08/11/2026GBX 14.36GBX 14.59
+1.60%
GBX 14.67GBX 14.45138 shs£209.32 million
08/10/2026GBX 14.24GBX 14.36
+0.87%
GBX 14.47GBX 14.2241 shs£206.02 million
08/07/2026GBX 14.24GBX 14.24
-0.04%
GBX 14.24GBX 14.192,138 shs£204.24 million
08/06/2026GBX 14.33GBX 14.24
-0.60%
GBX 14.27GBX 14.243 shs£204.33 million
08/05/2026GBX 14.37GBX 14.33
-0.27%
GBX 14.44GBX 14.3339 shs£205.56 million
08/04/2026GBX 14.24GBX 14.37
+0.88%
GBX 14.52GBX 14.34430 shs£206.12 million
08/03/2026GBX 13.84GBX 14.24
+2.95%
GBX 14.24GBX 14.096 shs£204.33 million
07/31/2026GBX 14.13GBX 13.84
-2.06%
GBX 13.99GBX 13.841,179 shs£198.48 million
07/30/2026GBX 14.19GBX 14.13
-0.43%
GBX 14.18GBX 14.0448 shs£202.65 million
07/29/2026GBX 14.06GBX 14.19
+0.92%
GBX 14.19GBX 14.139 shs£203.53 million
07/28/2026GBX 13.42GBX 14.06
+4.75%
GBX 14.10GBX 13.68259 shs£201.66 million
07/27/2026GBX 13.43GBX 13.42
-0.04%
GBX 13.53GBX 13.4022 shs£192.51 million
07/24/2026GBX 13.24GBX 13.43
+1.37%
GBX 13.43GBX 13.30148 shs£192.60 million
07/23/2026GBX 13.29GBX 13.24
-0.38%
GBX 13.26GBX 13.1478 shs£189.98 million
07/22/2026GBX 13.46GBX 13.29
-1.21%
GBX 13.48GBX 13.2040 shs£190.70 million
07/21/2026GBX 13.48GBX 13.46
-0.17%
GBX 13.49GBX 13.36102 shs£193.04 million
07/20/2026GBX 13.58GBX 13.48
-0.77%
GBX 13.51GBX 13.3426 shs£193.37 million
07/17/2026GBX 13.44GBX 13.58
+1.09%
GBX 13.81GBX 13.54128 shs£194.86 million
07/16/2026GBX 13.52GBX 13.44
-0.62%
GBX 13.57GBX 13.43423 shs£192.77 million

This page (LON:CYBG) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners